Total Payments
$22,593
2024 Payments
$184.15
Companies
21
Transactions
273
Medicare Patients
4,432
Medicare Billing
$624,231
Payment Breakdown by Category
Consulting$9,000 (39.8%)
Food & Beverage$5,797 (25.7%)
Other$4,068 (18.0%)
Travel$3,728 (16.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,000 | 3 | 39.8% |
| Food and Beverage | $5,797 | 259 | 25.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,000 | 1 | 17.7% |
| Travel and Lodging | $3,728 | 8 | 16.5% |
| Entertainment | $50.60 | 1 | 0.2% |
| Debt forgiveness | $17.53 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $19,909 | 65 | $0 (2024) |
| PFIZER INC. | $879.52 | 107 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $552.75 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $357.20 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $190.67 | 17 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $124.04 | 8 | $0 (2024) |
| iRhythm Technologies, Inc. | $109.63 | 5 | $0 (2023) |
| SPINAL ELEMENTS, INC. | $100.03 | 3 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $48.25 | 2 | $0 (2017) |
| Abbott Laboratories | $46.90 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $184.15 | 8 | E.R. Squibb & Sons, L.L.C. ($93.04) |
| 2023 | $432.61 | 27 | PFIZER INC. ($200.60) |
| 2022 | $403.37 | 30 | E.R. Squibb & Sons, L.L.C. ($120.99) |
| 2021 | $776.62 | 34 | BIOTRONIK INC. ($392.95) |
| 2020 | $899.78 | 31 | BIOTRONIK INC. ($571.63) |
| 2019 | $1,167 | 85 | BIOTRONIK INC. ($779.70) |
| 2018 | $9,806 | 21 | BIOTRONIK INC. ($9,718) |
| 2017 | $8,923 | 37 | BIOTRONIK INC. ($8,420) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $33.54 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $28.54 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Cardiovascular | ||||||
| 07/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/13/2024 | BIOTRONIK INC. | Orsiro Mission (Device) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/20/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/15/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/25/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/11/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/04/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/21/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/30/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/29/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Heart Failure | ||||||
| 05/26/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/20/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,195 | 2,289 | $475,736 | $158,070 |
| 2022 | 16 | 1,040 | 2,405 | $496,695 | $158,280 |
| 2021 | 20 | 1,169 | 2,353 | $507,341 | $170,038 |
| 2020 | 19 | 1,028 | 1,887 | $456,484 | $137,843 |
Total Patients
4,432
Total Services
8,934
Medicare Billing
$624,231
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 709 | $166,615 | $70,809 | 42.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 72 | 77 | $35,805 | $13,513 | 37.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 86 | 155 | $24,645 | $10,061 | 40.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 93 | $20,553 | $9,103 | 44.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 21 | 21 | $23,163 | $8,592 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $22,239 | $8,258 | 37.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 120 | 125 | $58,125 | $6,799 | 11.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 47 | $20,116 | $6,717 | 33.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 85 | 233 | $15,611 | $4,916 | 31.5% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 16 | 98 | $9,800 | $4,740 | 48.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 90 | 242 | $14,278 | $4,340 | 30.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $43,200 | $3,853 | 8.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 16 | 98 | $5,782 | $1,767 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 96 | 138 | $5,244 | $1,644 | 31.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 67 | 79 | $4,503 | $1,529 | 33.9% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 66 | 78 | $4,602 | $848.41 | 18.4% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 13 | 15 | $1,455 | $582.79 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 288 | 756 | $177,660 | $76,015 | 42.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 58 | 71 | $30,388 | $11,693 | 38.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 43 | 133 | $29,393 | $11,250 | 38.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 80 | 146 | $23,214 | $10,037 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $23,651 | $8,604 | 36.4% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2022 | 18 | 18 | $19,854 | $6,879 | 34.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 114 | 125 | $58,125 | $6,669 | 11.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 86 | 276 | $18,492 | $5,918 | 32.0% |
About Dr. Robert Orr, MD
Dr. Robert Orr, MD is a Cardiovascular Disease healthcare provider based in Escondido, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598734550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Orr, MD has received a total of $22,593 in payments from pharmaceutical and medical device companies, with $184.15 received in 2024. These payments were reported across 273 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($9,000).
As a Medicare-enrolled provider, Orr has provided services to 4,432 Medicare beneficiaries, totaling 8,934 services with total Medicare billing of $624,231. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Escondido, CA
- Active Since 03/14/2006
- Last Updated 12/01/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1598734550
Products in Payments
- BioMonitor 2 (Device) $7,432
- ELIQUIS (Drug) $1,193
- LifeVest (Device) $552.75
- Rivacor (Device) $129.16
- XARELTO (Drug) $125.95
- Solia (Device) $125.53
- ZIO XT Patch (Device) $109.63
- ENTRESTO (Drug) $102.76
- Medical Device (Device) $100.03
- Edora (Device) $88.56
- INVOKANA (Drug) $64.72
- BioMonitor (Device) $49.70
- SAMSCA (Drug) $48.25
- CARDIOMEMS (Device) $46.90
- NEXLETOL (Drug) $41.58
- CHANTIX (Drug) $28.40
- Hillrom - Cardiac Ambulatory Monitor (Device) $27.26
- Orsiro Mission (Device) $26.10
- Repatha (Biological) $22.05
- LINZESS (Drug) $21.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Escondido
Navinder Sawhney, Md, MD
Cardiovascular Disease — Payments: $126,745
Cardiovascular Disease $126,745
Mikhail Malek, M.d, M.D
Cardiovascular Disease — Payments: $17,358
Cardiovascular Disease $17,358
Roger Acheatel, M.d, M.D
Cardiovascular Disease — Payments: $11,818
Cardiovascular Disease $11,818
Hamed Bayat, M.d, M.D
Cardiovascular Disease — Payments: $9,746
Cardiovascular Disease $9,746
Dennis Leahy, M.d, M.D
Cardiovascular Disease — Payments: $6,956
Cardiovascular Disease $6,956
Dr. Young Lee, Md, MD
Cardiovascular Disease — Payments: $4,709
Cardiovascular Disease $4,709